NEURAPRO‐E study protocol: a multicentre randomized controlled trial of omega‐3 fatty acids and cognitive‐behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders
Early Intervention in Psychiatry2015Vol. 11(5), pp. 418–428
Citations Over TimeTop 10% of 2015 papers
Connie Markulev, Patrick D. McGorry, Barnaby Nelson, Hok Pan Yuen, Miriam Schaefer, Alison R. Yung, Andrew Thompson, Gregor Berger, Nilufar Mossaheb, Monika Schlögelhofer, Stefan Smesny, Lieuwe de Haan, Anita Riecher‐Rössler, Merete Nordentoft, Eric Chen, Swapna Verma, Ian B. Hickie, G. Paul Amminger
Abstract
This is the protocol of the NeuraproE study. Utilizing a large sample, results from this study will be important in informing indicated prevention strategies for schizophrenia and other psychotic disorders, which may be the strongest avenue for reducing the burden, stigmatization, disability and economic consequences of these disorders.
Related Papers
- → Randomized Controlled Drug Trials on Very Elderly Subjects: Descriptive and Methodological Analysis of Trials Published Between 1990 and 2002 and Comparison With Trials on Adults(2005)36 cited
- → Practice and Educational Effects of a Simulated Randomized Controlled Trial for Acupuncture School Teachers(2010)
- → Randomized Controlled Trials for Creating Scientific Evidence of the Efficacy and Safety of Complementary and Alternative Medicine(2004)
- A compatision between one visit RCT and several visit RCT for cracked teeth.(2007)
- Basical Clinical Observation of Cracked Tooth with One visit RCT(2003)